Related Experiment Video
Updated: Mar 23, 2026
11:28
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
10.9K
Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.
Jasmin Matuszak1, Jens Baumgartner2, Jan Zaloga1
1Cardiovascular Nanomedicine Unit, Section of Experimental Oncology and Nanomedicine (SEON), ENT-Department, University Hospital Erlangen, Glückstr. 10a, 91054 Erlangen, Germany.
Nanomedicine (London, England)
|March 23, 2016
Summary
Nanosystems for cardiovascular applications showed good endothelial cell tolerance in static and dynamic tests. Liposomal nanoparticles were safe in preliminary pig studies, indicating potential for clinical intravascular use.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cardiovascular Research
Background:
- Nanosystems offer promising therapeutic potential for cardiovascular diseases.
- Characterization of nanoparticle behavior in biological systems is crucial for safety and efficacy.
Purpose of the Study:
- To conduct physicochemical analysis of nanosystems for cardiovascular applications.
- To evaluate the toxicological profile of various nanoparticles in static and dynamic cell culture models.
Main Methods:
- Physicochemical properties (size, polydispersity, ζ-potential) of 10 nanoparticle systems were analyzed.
- Endothelial cell viability was assessed using real-time cell analysis and live-cell microscopy.
- Nanoparticle effects were studied in static conditions and a flow model simulating arterial bifurcations.
Main Results:
- Most nanosystems demonstrated good tolerability by primary human endothelial cells.
- Effective concentrations were up to 100 μg/ml in static and 400 μg/ml in dynamic conditions.
- Liposomal nanoparticles showed no hypersensitivity reaction in preliminary pig model studies.
Conclusions:
- Nanosystems exhibit favorable biocompatibility with endothelial cells under relevant physiological conditions.
- The findings support the potential clinical translation of these nanosystems for intravascular applications.
- Further in vivo validation is warranted to confirm safety and efficacy for cardiovascular interventions.
